This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations
A novel mitochondrial disease arises from mutations in HPDL, which codes for 4-hydroxyphenylpyruvate dioxygenase-like protein. The main purpose of this study is to establish a patient registry to gather medical data from consenting HPDL mutation patients worldwide. From longitudinal data, we will be able to figure out the natural history of the disease, and genotype-phenotype correlation. Dry blood spots will be collected to develop biomarkers to understand the disease better.
Study Type
OBSERVATIONAL
Enrollment
50
Participants who have been diagnosed with HPDL mutations will be enrolled to patient registry.
Dry blood splots require 500nl of blood.
Eun Hae Lee
San Diego, California, United States
RECRUITINGClinician questionnaire
Clinician-reported clinical and genetic confirmation of HPDL mutations
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.